ASP-5502

N/A

Report date: 2026/03/26 20:00:17
NME

Base Information

Drug NameASP-5502
Drug Alias NameASP5502ASP-5502
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStimulator of interferon genes inhibitors
TargetsStimulator of interferon genes
Therapy Area/IndicationsAutoimmune DiseasesSjogren-Larsson Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Global Development Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma Inc
Inactive CompaniesAstellas Pharma Global Development Inc
Active IndicationsAutoimmune Diseases
Inactive IndicationsSjogren-Larsson Syndrome

Other Information

ATC CodeN/A
Related LinksN/A